A new medication for treatment-resistant depression may help a subset of people who carry a specific genetic marker.

At lecture, Helen Mayberg presented findings showing electrical impulses in the brain can induce long-term benefits in patients.

Zalsupindole is an analogue of 5-MeO-DMT, a psychedelic drug derived from desert toad secretions. The company reported a ...

Patients with psychosis and preexisting skin conditions fare worse after treatment with an atypical antipsychotic than those ...

It’s about how ADHD symptoms impact on your day-to-day functioning. Here’s how clinicians assess this, and where people might ...

A new clinical trial has found that adding repeated intravenous ketamine infusions to standard care for hospitalized patients ...

Women who used transdermal hormone therapy (HT) to treat menopausal symptoms experienced lower rates of anxiety and ...

An RCT on avatar-based video-guided imagery for cLBP shows significant pain reduction with both acupuncture and touch simulation.

Delix Therapeutics, a clinical‑stage neuroscience company pioneering a new class of treatments known as neuroplastogens, today announced positive results from its Phase Ib clinical trial of ...

Trauma exposure and traumatic stress are common among adolescents, according to a study published online Oct. 27 in ...

Hurricane Melissa on Monday became the third Category 5 Atlantic hurricane in 2025, and all of them surged up within days/ ...